Ponatinib 45mg $150

So, Ponatinib is this BCR-ABL inhibitor, and it’s mainly used for two types of cancer: CML and this other one called Ph ALL. You know, the kind where the first treatments just don’t cut it. It’s made to go after more than one kinase, if you catch my drift.

The drug comes in two forms, like, a 15 mg tablet and a 45 mg one, both with that shiny coating stuff. The usual dose is 45 mg, once a day, no big deal, whether you eat or not. Each bottle holds about 30 tablets. Not bad, huh?